["Second opinion procedures" piggy bank or quality instrument? New scheme for regulation of specific drugs].
Briswalter
Stéphanie
S
GlaxoSmithKline GmbH & Co. KG, München. stephanie.briswalter@gsk.com
Heigl
Andreas
A
D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use*; D005858:Germany; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000191:economics; D007880:Legislation, Drug / Q000191:economics / Q000639:trends*; D011787:Quality of Health Care; D012017:Referral and Consultation / Q000331:legislation & jurisprudence*
D000959:Antihypertensive Agents